These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34356671)

  • 1. Osteopontin in Cardiovascular Diseases.
    Shirakawa K; Sano M
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin in Vascular Disease.
    Lok ZSY; Lyle AN
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):613-622. PubMed ID: 30727754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin: The Molecular Bridge between Fat and Cardiac-Renal Disorders.
    Vianello E; Kalousová M; Dozio E; Tacchini L; Zima T; Corsi Romanelli MM
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis.
    Abdelaziz Mohamed I; Gadeau AP; Hasan A; Abdulrahman N; Mraiche F
    Cells; 2019 Dec; 8(12):. PubMed ID: 31816901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of osteopontin in kidney diseases.
    Kaleta B
    Inflamm Res; 2019 Feb; 68(2):93-102. PubMed ID: 30456594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin Blockade Attenuates Renal Injury After Ischemia Reperfusion by Inhibiting NK Cell Infiltration.
    Cen C; Aziz M; Yang WL; Nicastro JM; Coppa GF; Wang P
    Shock; 2017 Jan; 47(1):52-60. PubMed ID: 27504800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.
    Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM;
    Atherosclerosis; 2018 Mar; 270():13-20. PubMed ID: 29407881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.
    Cho HJ; Cho HJ; Kim HS
    Curr Atheroscler Rep; 2009 May; 11(3):206-13. PubMed ID: 19361352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin: A Novel Therapeutic Target for Respiratory Diseases.
    Jia Q; Ouyang Y; Yang Y; Yao S; Chen X; Hu Z
    Lung; 2024 Feb; 202(1):25-39. PubMed ID: 38060060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Osteopontin in Liver Diseases.
    Wen Y; Jeong S; Xia Q; Kong X
    Int J Biol Sci; 2016; 12(9):1121-8. PubMed ID: 27570486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
    Psyrri A; Kalogeras KT; Wirtz RM; Kouvatseas G; Karayannopoulou G; Goussia A; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Economopoulou P; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
    J Transl Med; 2017 Feb; 15(1):30. PubMed ID: 28193231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of Osteopontin Ameliorates Acute Lung Injury Induced by Intestinal Ischemia-Reperfusion.
    Hirano Y; Aziz M; Yang WL; Ochani M; Wang P
    Shock; 2016 Oct; 46(4):431-8. PubMed ID: 26974422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
    Lorenzen J; Krämer R; Kliem V; Bode-Boeger SM; Veldink H; Haller H; Fliser D; Kielstein JT
    Eur J Clin Invest; 2010 Apr; 40(4):294-300. PubMed ID: 20486990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of global osteopontin and macrophage osteopontin in glomerular injury.
    Trostel J; Truong LD; Roncal-Jimenez C; Miyazaki M; Miyazaki-Anzai S; Kuwabara M; McMahan R; Andres-Hernando A; Sato Y; Jensen T; Lanaspa MA; Johnson RJ; Garcia GE
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F759-F768. PubMed ID: 29717936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin: its potential role in cancer of children and young adults.
    Karpinsky G; Fatyga A; Krawczyk MA; Chamera M; Sande N; Szmyd D; Izycka-Swieszewska E; Bien E
    Biomark Med; 2017 Apr; 11(4):389-402. PubMed ID: 28326824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.
    Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K
    Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin mediates murine transfusion-related acute lung injury via stimulation of pulmonary neutrophil accumulation.
    Kapur R; Kasetty G; Rebetz J; Egesten A; Semple JW
    Blood; 2019 Jul; 134(1):74-84. PubMed ID: 31076444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin knockout does not influence the severity of rectal damage in a preclinical model of radiation proctitis in mice.
    Blirando K; Mintet E; Buard V; Sabourin JC; Benderitter M; Milliat F; François A
    Dig Dis Sci; 2015 Jun; 60(6):1633-44. PubMed ID: 25577272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
    Wolak T
    Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice.
    Pei Z; Okura T; Nagao T; Enomoto D; Kukida M; Tanino A; Miyoshi K; Kurata M; Higaki J
    Sci Rep; 2016 Jun; 6():28882. PubMed ID: 27353458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.